Metropolis Healthcare Limited — Financials & Forensics
Sector: Healthcare · NSE: METROPOLIS · BSE: 542650 · ISIN: INE112L01020
19 Aug 2026
Add METROPOLIS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,228 Cr | ₹1,148 Cr | ₹1,208 Cr | ₹1,331 Cr | ₹1,646 Cr |
| EBITDA | ₹343 Cr | ₹288 Cr | ₹283 Cr | ₹303 Cr | ₹401 Cr |
| EBITDA margin | 27.9% | 25.1% | 23.4% | 22.8% | 24.4% |
| Profit after tax | ₹215 Cr | ₹143 Cr | ₹128 Cr | ₹146 Cr | ₹191 Cr |
Deeper analysis
Recent filings by Metropolis Healthcare Limited
-
Press Release
04 Aug 2026 · Financial Results
-
Investor Presentation
04 Aug 2026 · Financial Results
-
Outcome of Board Meeting
04 Aug 2026 · Financial Results
-
Allotment of 18,700 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020
04 Aug 2026 · Insider Trading
Never miss a filing again
About Metropolis Healthcare Limited on Indian Stock Alerts
Indian Stock Alerts tracks Metropolis Healthcare Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.